House Passes VA Funding Bill Allowing Medical Cannabis for Veterans

Funding Bill Clears House With Cannabis Provision Intact

The House passed H.R. 4486, the fiscal year 2027 Military Construction and Veterans Affairs Appropriations Act, by a vote of 229-196 on May 25, 2026. The bill allocates $157.8 billion for VA programs. It includes Section 228, which prohibits the use of federal funds to prevent VA physicians from recommending medical cannabis or completing forms required by state programs.

The provision doesn't require the VA to dispense cannabis or change its Schedule I classification under federal law. It removes the administrative barrier that's prevented VA doctors from participating in state medical cannabis programs since the Controlled Substances Act took effect in 1970.

Legislative History and Previous Attempts

Congress has debated VA medical cannabis access for more than a decade, with standalone bills repeatedly stalling in committee. Similar language passed the House in 2020 and 2022 as part of broader appropriations packages, but those provisions were stripped in conference negotiations with the Senate.

Key timeline:

• 2015: First standalone VA medical cannabis bill introduced (H.R. 667)
• 2020: House passes language in minibus appropriations; Senate removes it
• 2022: Identical outcome in FY 2023 cycle
• 2026: Language survives House floor vote in standalone VA funding bill

One difference this cycle: the provision was included in committee markup rather than added as a floor amendment, signaling leadership support.

What the Bill Does and Doesn't Do

Section 228 prohibits VA funds from being used to deny or penalize physicians who discuss cannabis with patients or complete state-required documentation. It doesn't authorize VA facilities to stock, dispense, or prescribe cannabis, which remains federally illegal under the Controlled Substances Act.

Veterans would still need to purchase cannabis from state-licensed dispensaries using private funds. VA physicians could:

• Discuss cannabis as a treatment option
• Complete state medical cannabis registry forms
• Recommend cannabis without risking disciplinary action

Veterans couldn't use VA insurance or federal dollars to purchase cannabis products.

Senate Prospects and Conference Risk

The Senate Appropriations Committee hasn't yet marked up its version of the VA funding bill. Past cycles show the provision faces significant conference-committee risk. Senate Republicans removed identical language in 2020 and 2022, citing concerns about federal endorsement of a Schedule I substance.

Sen. Jerry Moran (R-KS) chairs the Senate Veterans' Affairs Committee. He hasn't co-sponsored medical cannabis legislation. The Appropriations Subcommittee on Military Construction and Veterans Affairs is led by Sen. John Boozman (R-AR), who voted against cannabis provisions in previous cycles.

If the Senate version omits the language, the provision would need to survive conference negotiations in July or August.

Veteran Advocacy and Clinical Evidence

More than 4.6 million veterans live in states with legal medical cannabis programs, according to 2025 VA enrollment data. Advocacy groups including Iraq and Afghanistan Veterans of America and Veterans of Foreign Wars have endorsed access, citing evidence that cannabis may reduce opioid use among veterans with chronic pain and PTSD.

A 2024 study published in the Journal of the American Medical Association found that veterans in medical cannabis states had a 24.8% lower rate of opioid prescriptions compared to veterans in prohibition states. The VA's own research arm has called for clinical trials but can't conduct them under current federal restrictions.

What Happens Next

The bill now moves to the Senate. The Appropriations Committee is expected to release its draft in mid-June. If the Senate version includes the cannabis provision, it would advance to a floor vote. If not, House negotiators would need to defend the language in conference.

The fiscal year ends September 30, 2026. Without a final bill signed by that date, the government would operate under a continuing resolution that freezes FY 2026 policy—meaning the cannabis provision wouldn't take effect.

For full background on this issue, see the CannIntel topic hub on Veterans Medical Cannabis Access.